SEPSIS AND SEPTIC SHOCK: EPIDEMIOLOGY, CLINICAL PARAMETERS, AND PROGNOSTIC FACTORS IN A BRAZILIAN INTENSIVE CARE UNIT

Autores

  • Rebeka Caribé Badin
  • Liliane Rosa Alves Manaças
  • Ivone Antônia de Souza

DOI:

https://doi.org/10.25110/arqsaude.v27i7.2023-039

Palavras-chave:

Sepsis, Septic Shock, Microbiology, Hyperlactatemia, Hyperglycemia, Thrombocytopenia

Resumo

Sepsis is an organ dysfunction caused by a dysregulated host response to infection and is associated with high morbidity and mortality. The identification of prognostic markers in this syndrome has been a strategy to increase treatment efficacy. The objectives of this study were: 1) to describe the epidemiological and microbiological profile of septic patients and 2) to investigate the association between laboratory/clinical parameters and mortality rate, identifying prognostic markers. Using a prospective observational protocol, epidemiological, clinical and laboratory data were collected from adult patients with sepsis or septic shock admitted to a Brazilian Intensive Care Unit. During the study period, 120 patients were diagnosed with sepsis and 71.67% (n = 86) were included in the protocol. The overall mortality was 69.76% and chronic diseases were identified in 79.07% of cases. The mortality rates for sepsis and septic shock were 51.06% and 92.31%, respectively. SOFA scores on the first, third, and seventh days of hospitalization gradually increased for patients who had clinical worsening. Hyperlactatemia and hyperglycemia were identified in 45.9% and 27% of patients, respectively, and were associated with mortality. INR values greater than 1.5 or thrombocytopenia were related to 92.9% and 88.6% mortality, respectively. In the study, gender, age, ICU stay, site of infection and microbiological agent were not associated with the risk of death. However, the presence of comorbidities, high SOFA scores, three or more organ dysfunctions, and sepsis severity correlated directly with mortality rate.

Referências

ADAMZIK, M. et al. Whole blood impedance aggregometry as a biomarker for the diagnosis and prognosis of severe sepsis. Crit Care, v. 16, n. 5, p. R204, 2012.

ARNOLD, R. C. et al. Multicenter Study of Early Lactate Clearance as a Determinant of Survival in Patients with Presumed Sepsis. Shock, v. 32, n. 1, p. 35–39, 2009.

CAO, L. et al. Epidemiology and Mortality of Sepsis in Intensive Care Units in Prefecture-Level Cities in Sichuan, China: A Prospective Multicenter Study. Med Sci Monit, v. 27, 2021. Available from: https://www.medscimonit.com/abstract/index/idArt/932227. Accessed on: Feb 12. 2023.

CARRILLO-ESPER, R.; CARRILLO-CÓRDOVA, J. R.; CARRILLO-CÓRDOVA, L. D. [Epidemiological study of sepsis in Mexican intensive care units]. Cir Cir, v. 77, n. 4, p. 301–8; 279–85, 2009.

DAUDEL, F. et al. Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study. Crit Care, v. 13, n. 2, p. R42, 2009.

DUGAR, S.; CHOUDHARY, C.; DUGGAL, A. Sepsis and septic shock: Guideline-based management. CCJM, v. 87, n. 1, p. 53–64, 2020.

ENGEL, C. et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med, v. 33, n. 4, p. 606–18, 2007.

EVANS, L. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med, v. 47, n. 11, p. 1181–247, 2021.

FAN, S. L. et al. Diagnosing sepsis – The role of laboratory medicine. Clinica Chimica Acta, v. 460, p. 203–10, 2016.

FLEISCHMANN-STRUZEK, C. et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med, v. 46, n. 8, p. 1552–62, 2020.

GREEN, J. P. et al. Hyperlactatemia Affects the Association of Hyperglycemia with Mortality in Nondiabetic Adults with Sepsis. Sinert R, editor. Acad Emerg Med, v. 19, n. 11, p. 1268–1275, 2012.

JACOBI, J. The pathophysiology of sepsis-2021 update: Part 1, immunology and coagulopathy leading to endothelial injury. Am J Health Syst Pharm, v. 79, n. 5, p. 329–337, 2022.

JARCZAK, D.; KLUGE, S.; NIERHAUS, A. Sepsis—Pathophysiology and Therapeutic Concepts. Front Med, v. 8, n. 628302, 2021. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160230/pdf/fmed-08-628302.pdf. Accessed on: Mar 15. 2023.

JEGANATHAN, N. et al. The characteristics and impact of source of infection on sepsis-related ICU outcomes. J Crit Care, v. 41, p. 170–6, 2017.

JUNCAL, V. R. et al. Impacto clínico do diagnóstico de sepse à admissão em UTI de um hospital privado em Salvador, Bahia. J Bras Pneumol, v. 37, n. 1, p. 85–92, 2011.

KOURY J. C. DE A.; LACERDA, H. R.; BARROS NETO, A. J. DE. [Characteristics of septic patients in an intensive care unit of a tertiary private hospital from Recife, northeast of Brazil]. Rev Bras Ter Intensiva, v. 18, n. 1, p. 52–8, 2006.

LEVERVE, X. Hyperglycemia and oxidative stress: complex relationships with attractive prospects. Intensive Care Med, v. 29, n. 4, p. 511–514, 2003.

LI, Y. et al. Comparison of culture-negative and culture-positive sepsis or septic shock: a systematic review and meta-analysis. Crit Care, v. 25, n. 1, p. 167, 2021.

LIANG, L.; MOORE, B.; SONI, A. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2017. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US), 2006. Available from: http://www.ncbi.nlm.nih.gov/books/NBK561141/. Accessed on: Jan 20, 2023.

MONTIEL-JARQUÍN, Á. et al. Lactate Clearance is a Prognostic Factor in Patients on Shock State. Electron J Gen Med, v. 9, n. 2, p. 98–103, 2012. Available from: https://www.ejgm.co.uk/download/lactate-clearance-is-a-prognostic-factor-in-patients-on-shock-state-6959.pdf. Accessed on: Feb 12. 2023.

NIEDERMAN, M. S. et al. Initial antimicrobial management of sepsis. Crit Care, v. 25, n. 1, p. 307, 2021.

PAOLI, C. J. et al. Reynolds MA, Sinha M, Gitlin M, Crouser E. Epidemiology and Costs of Sepsis in the United States—An Analysis Based on Timing of Diagnosis and Severity Level*: Critical Care Medicine, v. 46, n. 12, p. 1889–97, 2018.

PRESCOTT, H. C.; ANGUS, D. C. Enhancing Recovery om Sepsis: A Review. JAMA, v. 319, n. 1, p. 62-75, 2018.

QUINTANO NEIRA, R. A.; HAMACHER, S.; JAPIASSÚ, A. M. Epidemiology of sepsis in Brazil: Incidence, lethality, costs, and other indicators for Brazilian Unified Health System hospitalizations from 2006 to 2015. Dal Pizzol F, editor. PLoS ONE, v. 13, n. 4, p. e0195873, 2018. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898754/pdf/pone.0195873.pdf. Accessed on: Feb 12. 2023.

REBOUÇAS, A. S. et al. Utilização do biomarcador inovador de dano renal Cistatina C urinária em recém-nascidos prematuros com sepse e infecção neonatal. Arquivos de Ciências da Saúde da UNIPAR, Umuarama, v.27, n.4, p.2045-2064, 2023.

RODRÍGUEZ, F. et al. The epidemiology of sepsis in Colombia: A prospective multicenter cohort study in ten university hospitals*: Critical Care Medicine, v. 39, n. 7, p. 1675–82, 2011.

RUDD, K. E. et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. The Lancet, v. 395, n. 10219, p. 200–11, 2020.

SALES JÚNIOR, J. A. L. et al. [An epidemiological study of sepsis in Intensive Care Units: Sepsis Brazil study]. Rev Bras Ter Intensiva. v. 18, n. 1, p. 9–17, 2006.

SCHUETZ, P. et al. Diabetes Is Not Associated with Increased Mortality in Emergency Department Patients with Sepsis. Annals of Emergency Medicine, v. 58, n. 5, p. 438–44, 2011.

SCHULTZ, M. J. et al. Current challenges in the management of sepsis in ICUs in resource-poor settings and suggestions for the future. Intensive Care Med, v. 43, n. 5, p. 612–24, 2017.

SILVA, E. et al. Brazilian Sepsis Epidemiological Study (BASES study). Crit Care, v. 8, n. 4, p. R251–260, 2004.

SINGER, M. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, v. 315, n. 8, p. 801-810, 2016.

SOGAYAR, A. M. C. et al. A multicentre, prospective study to evaluate costs of septic patients in Brazilian intensive care units. Pharmacoeconomics, v. 26, n. 5, p. 425–34, 2008.

TUFAN, Z. K. The Knowledge of the Physicians about Sepsis Bundles is Suboptimal: A Multicenter Survey. JCDR, 2015. Available from: http://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2015&volume=9&issue=7&page=OC13&issn=0973-709x&id=6220. Accessed on: Feb 12. 2023.

UENO, H. et al. Coagulation/fibrinolysis abnormality and vascular endothelial damage in the pathogenesis of thrombocytopenic multiple organ failure: Critical Care Medicine, v. 30, n. 10, p. 2242–2248, 2002.

VINCENT, J. L. et al. International Study of the Prevalence and Outcomes of Infection in Intensive Care Units. JAMA, v. 302, n. 21, p. 2323-2329, 2009.

VINCENT, J. L. et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med, v. 34, n. 2, p. 344–53, 2006.

VINCENT, J. L. et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine (see contributors to the project in the appendix). Intensive Care Med, v. 22, n. 7, p. 707–10, 1996.

ZAHAR, J. R. et al. Outcomes in severe sepsis and patients with septic shock: Pathogen species and infection sites are not associated with mortality*: Critical Care Medicine, v. 39, n. 8, p. 1886–95, 2011.

ZÁHOREC, R. et al. Epidemiology of Severe Sepsis in Intensive Care Units in the Slovak Republic. Infection, v. 33, n. 3, p. 122–128, 2005.

ZANON, F. et al. Sepsis in the intensive care unit: etiologies, prognostic factors and mortality. Rev Bras Ter Intensiva, v. 20, n. 2, p. 128–34, 2008.

Downloads

Publicado

24-07-2023

Como Citar

BADIN, Rebeka Caribé; MANAÇAS, Liliane Rosa Alves; DE SOUZA, Ivone Antônia. SEPSIS AND SEPTIC SHOCK: EPIDEMIOLOGY, CLINICAL PARAMETERS, AND PROGNOSTIC FACTORS IN A BRAZILIAN INTENSIVE CARE UNIT. Arquivos de Ciências da Saúde da UNIPAR, [S. l.], v. 27, n. 7, p. 3844–3861, 2023. DOI: 10.25110/arqsaude.v27i7.2023-039. Disponível em: https://revistas.unipar.br/index.php/saude/article/view/9564. Acesso em: 22 nov. 2024.

Edição

Seção

Artigos